Membranous glomerulonephritis secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Early detection and treatment of hepatitis C can be preventive for developing membranous glomerulopathy | Early detection and treatment of [[Hepatitis C/Lab Tests|hepatitis C]] can be preventive for developing membranous glomerulopathy. | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
*The treatment of hepatitis | *Effective measures for primary prevention of membranous glomerulonephritis include:<ref name="LaiLi1991">{{cite journal|last1=Lai|first1=Kar Neng|last2=Li|first2=Philip K.T.|last3=Lui|first3=Siu Fai|last4=Au|first4=Tak Cheong|last5=Tam|first5=John S.L.|last6=Tong|first6=Kwok Lung|last7=Lai|first7=Fernand Mac-Moune|title=Membranous Nephropathy Related to Hepatitis B Virus in Adults|journal=New England Journal of Medicine|volume=324|issue=21|year=1991|pages=1457–1463|issn=0028-4793|doi=10.1056/NEJM199105233242103}}</ref><ref name="pmid40692862">{{cite journal |vauthors=Gyapay G, Jeney A, Lapis K |title=Drug action and chromatin structure. I. Adriamycin binding to core particle of nucleosomes and subsequent enhanced DNA fragmentation induced by micrococcal nuclease |journal=Neoplasma |volume=32 |issue=5 |pages=521–8 |date=1985 |pmid=4069286 |doi= |url=}}</ref> | ||
**The treatment of [[Hepatitis c|hepatitis C]] can lower the risk for membranous glomerulonephritis<ref name="pmid4069286">{{cite journal |vauthors=Gyapay G, Jeney A, Lapis K |title=Drug action and chromatin structure. I. Adriamycin binding to core particle of nucleosomes and subsequent enhanced DNA fragmentation induced by micrococcal nuclease |journal=Neoplasma |volume=32 |issue=5 |pages=521–8 |date=1985 |pmid=4069286 |doi= |url=}}</ref> | |||
**Safe sexual practice can prevent the risk of [[Human Immunodeficiency Virus|HIV]] which can eventually decreases the risk of MN. | |||
**Safe sexual practice can prevent the risk of [[Syphilis, congenital|syphilis]] which can be preventive the risk of MN. | |||
==References== | ==References== |
Revision as of 20:08, 24 July 2018
Membranous glomerulonephritis Microchapters |
Differentiating Membranous glomerulonephritis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Membranous glomerulonephritis secondary prevention On the Web |
American Roentgen Ray Society Images of Membranous glomerulonephritis secondary prevention |
Membranous glomerulonephritis secondary prevention in the news |
Directions to Hospitals Treating Membranous glomerulonephritis |
Risk calculators and risk factors for Membranous glomerulonephritis secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Ahsan Hussain, M.D.[2]
Overview
Early detection and treatment of hepatitis C can be preventive for developing membranous glomerulopathy.
Secondary Prevention
- Effective measures for primary prevention of membranous glomerulonephritis include:[1][2]
- The treatment of hepatitis C can lower the risk for membranous glomerulonephritis[3]
- Safe sexual practice can prevent the risk of HIV which can eventually decreases the risk of MN.
- Safe sexual practice can prevent the risk of syphilis which can be preventive the risk of MN.
References
- ↑ Lai, Kar Neng; Li, Philip K.T.; Lui, Siu Fai; Au, Tak Cheong; Tam, John S.L.; Tong, Kwok Lung; Lai, Fernand Mac-Moune (1991). "Membranous Nephropathy Related to Hepatitis B Virus in Adults". New England Journal of Medicine. 324 (21): 1457–1463. doi:10.1056/NEJM199105233242103. ISSN 0028-4793.
- ↑ Gyapay G, Jeney A, Lapis K (1985). "Drug action and chromatin structure. I. Adriamycin binding to core particle of nucleosomes and subsequent enhanced DNA fragmentation induced by micrococcal nuclease". Neoplasma. 32 (5): 521–8. PMID 4069286.
- ↑ Gyapay G, Jeney A, Lapis K (1985). "Drug action and chromatin structure. I. Adriamycin binding to core particle of nucleosomes and subsequent enhanced DNA fragmentation induced by micrococcal nuclease". Neoplasma. 32 (5): 521–8. PMID 4069286.